版权说明 操作指南
首页 > 成果 > 详情

CHOP overexpression sensitizes human non-small cell lung cancer cells to cisplatin treatment by Bcl-2/JNK pathway

认领
导出
反馈
分享
QQ微信 微博
成果类型:
期刊论文
作者:
Wang, Li-Le;Hu, Rui-Cheng;Dai, Ai-Guo;Tan, Shuang-Xiang;Xu, Ming;...
作者机构:
[Kong, Chun-Chu; Hu, Rui-Cheng; Tan, Shuang-Xiang; Chen, Yun-Rong; Wang, Li-Le; Fu, Dai-Yan] Hunan Normal Univ, Affiliated Hosp 1, Hunan Prov Peoples Hosp, Dept Resp Med, Changsha 410016, Peoples R China.
[Dai, Ai-Guo] Hunan Univ Chinese Med, Med Sch, Dept Resp Dis, Changsha 410208, Peoples R China.
[Xu, Ming] Hunan Normal Univ, Affiliated Hosp 1, Hunan Prov Peoples Hosp, Dept Gastroenterol Med, Changsha 410016, Peoples R China.
语种:
英文
关键词:
NSCLC;CHOP;cisplatin;Bcl-2;JNK;apoptosis
期刊:
American Journal of Translational Research
ISSN:
1943-8141
年:
2021
卷:
13
期:
6
页码:
6279-6287
机构署名:
本校为其他机构
院系归属:
医学院
摘要:
C/EBP homologous protein (CHOP), a 29 kDa cellular protein, plays a role in regulating tumor proliferation, differentiation, metabolism, cell death, and in tumor resistance to chemotherapy. Non-small cell lung cancer (NSCLC) is a tumor of the respiratory system and drug resistance is prevalent among NSCLC clinical cell cultures. Herein, our study elucidated the effect of CHOP on NSCLC cells with cisplatin resistance and its mechanism. In a NSCLC cell line with cisplatin-resistance, CHOP expression was decreased, compared with A549 cells. Overexpression of CHOP decreased the cell viability and ...

反馈

验证码:
看不清楚,换一个
确定
取消

成果认领

标题:
用户 作者 通讯作者
请选择
请选择
确定
取消

提示

该栏目需要登录且有访问权限才可以访问

如果您有访问权限,请直接 登录访问

如果您没有访问权限,请联系管理员申请开通

管理员联系邮箱:yun@hnwdkj.com